Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
The sensitivity of molecular diagnostics could be affected by nucleotide variants in pathogen genes, and the sites affected by such variants should be monitored. We report a single-nucleotide variant (SNV) in the nucleocapsid (N) gene of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), i.e., G29179T, which impairs the diagnostic sensitivity of the Xpert Xpress SARS-CoV-2 assay (Cepheid, Sunnyvale, CA, USA). We observed significant differences between the threshold cycle (Ct) values for envelope (E) and N genes and confirmed the SNV as the cause of the differences using Sanger sequencing. This SNV, G29179T, is the most prevalent in Korea and is associated with the B.1.497 virus lineage, which is dominant in Korea. Clinical laboratories should be aware of the various SNVs in the SARS-CoV-2 genome and consider their potential effects on the diagnosis of coronavirus disease 2019.
Abstract
The sensitivity of molecular diagnostics could be affected by nucleotide variants in pathogen genes, and the sites affected by such variants should be monitored. We report a single-nucleotide variant (SNV) in the nucleocapsid (N) gene of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), i.e., G29179T, which impairs the diagnostic sensitivity of the Xpert Xpress SARS-CoV-2 assay (Cepheid, Sunnyvale, CA, USA). We observed significant differences between the threshold cycle (Ct) values for envelope (E) and N genes and confirmed the SNV as the cause of the differences using Sanger sequencing. This SNV, G29179T, is the most prevalent in Korea and is associated with the B.1.497 virus lineage, which is dominant in Korea. Clinical laboratories should be aware of the various SNVs in the SARS-CoV-2 genome and consider their potential effects on the diagnosis of coronavirus disease 2019.
참고문헌 (12)
- "Common primer check for high quality genomes" (2021)[URL]
- Artesi M, "A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E Gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay", J Clin Microbiol, 58, pp.e01598-20~ (2020)
- Li Z, "A confirmed case of SARS-CoV-2 pneumonia with routine RT-PCR negative and virus variation in Guangzhou, China", Clin Infect Dis, pp.ciaa941~ (2020)
- Osório NS, "Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays", Lancet Infect Dis, 21, pp.166~167 (2021)
- Álvarez-Díaz DA, "Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia", Infect Genet Evol, 84, pp.104390~ (2020)
- Vanaerschot M, "Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by Reverse Transcription-PCR", J Clin Microbiol, 59, pp.e02369-20~ (2020)
- Ziegler K, "SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene", Euro Surveill, 25, pp.2001650~ (2020)
- Wolters F, "Multi-center evaluation of cepheid xpert xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic", J Clin Virol, 128, pp.104426~ (2020)
- Cameron A, "Extraction-free methods for the detection of SARS-CoV-2 by reverse transcription-PCR : a comparison with the Cepheid Xpert Xpress SARS-CoV-2 assay across two medical centers", J Clin Microbiol, 59, pp.e02643-20~ (2021)
- "Research use only 2019-novel coronavirus (2019-nCoV) real-time RT-PCR primers and probes" (2020)[URL]
- Rambaut A, "A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology", Nat Microbiol, 5, pp.1403~1407 (2020)
- "PANGO Lineages" (2021)[URL]